Loading…

Loading grant details…

Completed RESEARCH GRANT Europe PMC

Clinical Phenotyping To Enable Targeted Treatment Of Persistent Cognitive Symptoms After COVID-19

£2.91M GBP

Funder Chief Scientist Office
Recipient Organization University of Edinburgh
Country United Kingdom
Start Date Feb 01, 2021
End Date Jan 31, 2023
Duration 729 days
Number of Grantees 1
Roles Award Holder
Data Source Europe PMC
Grant ID COV/LTE/20/26
Grant Description

People with ‘Long Covid’ describe memory and concentration problems.

Studies examining how people perform on memory and intelligence tests have found that patients who have had COVID-19 perform worse than those who have not. But to date, we don’t know why they have poorer cognitive function. Memory and concentration symptoms in ‘Long Covid’ are likely to have different causes in different people.

Some may have had direct infection or inflammation of the brain, or blockages to blood vessels in the brain. In others, underlying brain disease may have been ‘unmasked’ by COVID-19.

Some may have functional cognitive disorders, where memory and concentration problems are the result of changes in the brain’s ‘software’. In others, anxiety, low mood or fatigue may contribute to their symptoms. Each of these conditions has a different outcome and treatment.

This study aims to closely examine 100 people with persisting cognitive symptoms after COVID-19, assessing the cognitive problems as well as markers of brain damage, inflammation, and underlying degenerative brain disease.

All Grantees

University of Edinburgh

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant